Phytonadione
NDC Package 69097-540-49
Package Information
Phytonadione is vitamin K is used to treat and prevent low levels of certain substances (blood clotting factors) that your body naturally produces. Marketed by Cipla Usa Inc., this product is identified by NDC 69097-540 and is authorized under FDA application ANDA212424.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 69097 - Cipla Usa Inc.
- 69097-540 - Phytonadione
- 69097-540-49 - 5 TRAY in 1 CARTON / 5 AMPULE in 1 TRAY (69097-540-30) / .5 mL in 1 AMPULE
- 69097-540 - Phytonadione
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 69097-540-49 identifies a specific commercial package of 5 tray in 1 carton / 5 ampule in 1 tray (69097-540-30) / .5 ml in 1 ampule of Phytonadione, labeled by Cipla Usa Inc.. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Cipla Usa Inc. on April 23, 2022. The current certification is valid through July 25, 2022.
What are the primary indications for this medication?
Vitamin K is used to treat and prevent low levels of certain substances (blood clotting factors) that your body naturally produces. These substances help your blood to thicken and stop bleeding normally (such as after an accidental cut or injury). Low levels of blood clotting factors increase the risk for unusual bleeding. Low levels may be caused by certain medications (such as warfarin) or medical conditions (such as obstructive jaundice). Vitamin K helps to treat and prevent unusual bleeding by increasing the body's production of blood clotting factors.
How is this Cipla Usa Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 69097054049. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.